Quantum Corporation

Quantum Accused of Improperly Recognizing Revenue

According to the complaint, Quantum Corporation (NYSE: QTM) repeatedly reported positive financial results in its public filings, noting that the company was "focused on building on our momentum to drive continued growth, profitability and cash flow." Quantum continued to deliver purported solid financial results until August 9, 2017, when the company reported results that fell short of expectations.  Nonetheless, Quantum assured investors that it would take aggressive action to improve cost structure and generate consistent growth and profitability.  According to the complaint, however, the company's financial problems were much more widespread than Quantum had led investors to believe.  On February 8, 2018, Quantum announced that it was postponing the release of its fiscal third quarter 2018 results and its earnings conference call, confessing that the company had received a subpoena from the U.S. Securities and Exchange Commission regarding its accounting practices and internal controls related to revenue recognition for transactions beginning April 1, 2016.  On this news, Quantum's stock fell nearly 30% to close at $3.90 per share on February 8, 2018.

Quantum Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can send us a message via the
Shareholder Information form below.

Send us a message for more information.

Additional Alerts for Shareholders

Pharmaceutist reaching for medications on pharmacy shelves

uniQure N.V. Class Action Lawsuit

Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Leading Drug Candidate, AMT-130 Robbins LLP informs stockholders

Read More »
Free!
Skip to content